Kersten Villringer Selected Research

Retinaldehyde (Retinal)

12/2023

Diffusion-weighted magnetic resonance imaging in early central retinal artery occlusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kersten Villringer Research Topics

Disease

14	Stroke (Strokes) 01/2021 - 01/2013
12	Ischemic Stroke 01/2021 - 01/2013
3	Ischemia 12/2023 - 01/2016
2	Infarction (Infarctions) 01/2020 - 01/2017
1	Retinal Artery Occlusion 12/2023
1	Vision Disorders (Hemeralopia) 12/2023
1	Tics (Tic) 01/2023
1	Parkinson Disease (Parkinson's Disease) 10/2021
1	Cognitive Dysfunction 10/2021
1	Inflammation (Inflammations) 01/2021
1	Dementia (Dementias) 01/2019
1	Hemorrhage 01/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018
1	Atrial Fibrillation 01/2018
1	Cerebral Infarction 01/2018
1	Cerebral Hemorrhage 01/2017

Drug/Important Bio-Agent (IBA)

4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 01/2013
2	Troponin T (Troponin T1)IBA 01/2019 - 04/2017
2	Contrast MediaIBA 01/2017 - 11/2015
1	Retinaldehyde (Retinal)IBA 12/2023
1	4- phenyl- 5,5- dicarbethoxy- 2- pyrrolidinoneIBA 10/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Vascular Endothelial Growth FactorsIBA 01/2021
1	deoxyhemoglobinIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	TroponinIBA 01/2019
1	Phenprocoumon (Liquamar)FDA Link 11/2018
1	Indicators and Reagents (Reagents)IBA 01/2017
1	GadoliniumIBA 01/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	SteamIBA 01/2016
1	gadobutrolIBA 11/2015
1	cyclo(Arg-Pro) (CI 4)IBA 04/2014

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2013
2	Contraindications 01/2015 - 04/2014
1	Patient Discharge 01/2023
1	Catheters 01/2018
1	Activities of Daily Living (ADL) 01/2018
1	Thrombolytic Therapy 06/2013
1	Aftercare (After-Treatment) 01/2013